; and (2) the destruction of chemical warfare materiel of the United States that is not covered by section 1412 of such Act. 1404. Drug Interdiction and Counter-Drug Activities, Defense-wide Funds are hereby authorized to be appropriated for the Department of Defense for fiscal year 2020 for expenses, not otherwise provided for, for Drug Interdiction and Counter-Drug Activities, Defense-wide, in the amount of $799,402,000. 1405. Defense Inspector General Funds are hereby authorized to be appropriated for the Department of Defense for fiscal year 2020 for expenses, not otherwise provided for, for the Office of the Inspector General of the Department of Defense, in the amount of $363,499,000, of which— (1) $360,201,000 is for Operation and Maintenance; (2) $2,965,000 is for Research, Development, Test and Evaluation; and (3) $333,000 is for Procurement. 1406. Defense Health Program Funds are hereby authorized to be appropriated for the Department of Defense for fiscal year 2020 for expenses, not otherwise provided for, for the Defense Health Program, in the amount of $32,998,687,000, of which— (1) $31,812,090,000 is for Operation and Maintenance; (2) $732,273,000 is for Research, Development, Test, and Evaluation; and (3) $454,324,000 is for Procurement. B Other matters 1411. Authority for transfer of funds to joint Department of Defense–Department of Veterans Affairs Medical Facility Demonstration Fund for Captain James A. Lovell Health Care Center, Illinois (a) Authority for transfer of funds Of the funds authorized to be appropriated for section 1406 and available for the Defense Health Program for operation and maintenance, $127,000,000 may be transferred by the Secretary of Defense to the Joint Department of Defense–Department of Veterans Affairs Medical Facility Demonstration Fund established by subsection (a)(1) of section 1704 of the National Defense Authorization Act for Fiscal Year 2010 ( Public Law 111–84